Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice.

Tamara RusmanSaskia Ten WoldeSjoerd M EuserTjeerd van der PloegOdile van HallIrene E van der Horst-Bruinsma

Published in: International journal of rheumatic diseases (2018)

Females stayed on the same TNFi for a significantly shorter period compared to males (33.4 vs. 44.9 months) and the most important reason to stop or switch the drug was inefficacy. Moreover, females seemed to be more prone to infections during TNFi treatment than males.

Keyphrases

ankylosing spondylitis
healthcare
primary care
emergency department
combination therapy
systemic lupus erythematosus
replacement therapy
electronic health record